{"id":914062,"date":"2025-11-26T09:04:34","date_gmt":"2025-11-26T14:04:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/"},"modified":"2025-11-26T09:04:34","modified_gmt":"2025-11-26T14:04:34","slug":"mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/","title":{"rendered":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty"},"content":{"rendered":"
\n

WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) — Mural Oncology plc (Nasdaq: MURA) (\u201cMural<\/strong>\u201d)\u00a0announces that, in accordance with the terms of the transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (\u201cXOMA Royalty<\/strong>\u201d), XRA 5 Corp. (\u201cSub<\/strong>\u201d) and Mural announced on August 20, 2025 (the \u201cTransaction Agreement<\/strong>\u201d), the Additional Price Per Share (as defined in the Transaction Agreement) has been finally determined in accordance with Clause 2.4 of the Transaction Agreement as $0.000. As a result, the total cash consideration payable to Mural shareholders on closing of the Acquisition (as defined below) will be $2.035 in cash per share.<\/p>\n

As previously announced on August 20, 2025, XOMA Royalty, Sub and Mural entered into the Transaction Agreement pursuant to which Sub, a wholly-owned subsidiary of XOMA Royalty, has agreed to acquire the entire issued and to be issued share capital of Mural (the \u201cAcquisition<\/strong>\u201d) pursuant to an Irish High Court sanctioned \u201cscheme of arrangement\u201d under Chapter 1 of Part 9 of the Irish Companies Act of 2014 (the \u201cScheme<\/strong>\u201d).<\/p>\n

The Acquisition is expected to close in early December 2025, subject to the satisfaction of the outstanding closing conditions and the sanction of the Scheme by the Irish High Court.<\/p>\n

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION<\/p>\n

FOR IMMEDIATE RELEASE<\/p>\n

\n Enquiries<\/strong>\n <\/p>\n

Mural Oncology plc
ir@muraloncology.com<\/a><\/p>\n

Lucid Capital Markets, LLC (Financial Adviser to Mural)
570 Lexington Ave, 40th Floor
New York, NY 10022<\/p>\n

\n Cautionary Note Regarding Forward-Looking Statements<\/strong>\n <\/p>\n

Statements contained in this announcement regarding matters that are not historical facts are \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to Mural, XOMA Royalty or Sub. Forward-looking statements are intended to be identified by words such as \u201canticipate\u201d, \u201ctarget\u201d, \u201cexpect\u201d, \u201cestimate\u201d, \u201cintend\u201d, \u201cplan\u201d, \u201cbelieve\u201d, \u201cwill\u201d, \u201cmay\u201d, \u201cwould\u201d, \u201ccould\u201d or \u201cshould\u201d or other words of similar meaning or the negative thereof. Forward-looking statements include but are not limited to statements regarding Mural, XOMA Royalty and Sub\u2019s intention to consummate the Acquisition and the expected timing of the closing of the Acquisition.<\/p>\n

These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results to be materially different from those expressed or implied by such forward-looking statements. Risks and uncertainties that may cause actual results to differ from expectations include: uncertainties as to the possibility that closing conditions for the Acquisition may not be satisfied or waived, including the failure to receive sanction of the Scheme by the Irish High Court; the other risks and uncertainties pertaining to Mural\u2019s business, including those described in Mural\u2019s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (\u201cSEC\u201d) and the definitive proxy statement filed with the SEC on September 23, 2025, as well as Mural\u2019s subsequent filings with the SEC; and other potential risks and uncertainties related to XOMA Royalty, including those described in more detail in XOMA Royalty\u2019s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and its other filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. All subsequent oral or written forward-looking statements attributable to Mural, XOMA Royalty or Sub or any persons acting on their behalf are expressly qualified in their entirety by the cautionary statement above. None of Mural, XOMA Royalty or Sub undertake any obligation to update or revise the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.<\/p>\n

\n Statement Required by the Irish Takeover Rules\u00a0<\/strong>\n <\/p>\n

The directors of Mural accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the directors of Mural (who have taken all reasonable care to ensure such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.<\/p>\n

\n Disclosure Requirements of the Irish Takeover Rules <\/strong>\n <\/p>\n

Under Rule 8.3(b) of the Irish Takeover Rules, any person who is, or becomes, \u201cinterested\u201d (directly or indirectly) in 1% or more of any class of \u201crelevant securities\u201d of Mural must disclose all \u201cdealings\u201d in such \u201crelevant securities\u201d during the \u201coffer period\u201d. The disclosure of a \u201cdealing\u201d in \u201crelevant securities\u201d by a person to whom Rule 8.3(b) applies must be made by no later than 3:30pm (U.S. Eastern Time) on the \u201cbusiness day\u201d following the date of the relevant \u201cdealing\u201d. A dealing disclosure must contain the details specified in Rule 8.6(b) of the Irish Takeover Rules, including details of the dealing concerned and of the person\u2019s interests and short positions in any \u201crelevant securities\u201d of Mural.<\/p>\n

All \u201cdealings\u201d in \u201crelevant securities\u201d of Mural by a bidder, or by any party acting in concert with a bidder, must also be disclosed by no later than 12:00 noon (U.S. Eastern Time) on the \u201cbusiness day\u201d following the date of the relevant \u201cdealing\u201d.<\/p>\n

If two or more persons co-operate on the basis of an agreement, either express or tacit, either oral or written, to acquire an \u201cinterest\u201d in \u201crelevant securities\u201d of Mural, they will be deemed to be a single person for the purpose of Rule 8.3(a) and (b) of the Irish Takeover Rules.<\/p>\n

A disclosure table, giving details of the companies in whose \u201crelevant securities\u201d dealing disclosures should be made, can be found on the Irish Takeover Panel\u2019s website at www.irishtakeoverpanel.ie<\/a>.<\/p>\n

\u201cInterests in securities\u201d arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an \u201cinterest\u201d by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.<\/p>\n

Terms in quotation marks in this section are defined in the Irish Takeover Rules, which can also be found on the Irish Takeover Panel\u2019s website.<\/p>\n

If you are in any doubt as to whether or not you are required to disclose a \u201cdealing\u201d under Rule 8, please consult the Irish Takeover Panel\u2019s website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020.<\/p>\n

\n General<\/strong>\n <\/p>\n

The release, publication or distribution of this announcement in or into certain jurisdictions may be restricted by the laws of those jurisdictions. Accordingly, copies of this announcement and all other documents relating to the Acquisition are not being, and must not be, released, published, mailed or otherwise forwarded, distributed or sent in, into or from any such restricted jurisdictions. Persons receiving such documents (including, without limitation, nominees, trustees and custodians) should observe these restrictions. Failure to do so may constitute a violation of the securities laws of any such jurisdiction. To the fullest extent permitted by applicable law, each of Mural, XOMA Royalty and Sub disclaims any responsibility or liability for the violations of any such restrictions by any person.<\/p>\n

\n Publication on a Website<\/strong>\n <\/p>\n

In accordance with Rule 26.1 of the Irish Takeover Rules, a copy of this announcement will be available on Mural\u2019s website at https:\/\/ir.muraloncology.com\/ by no later than 12:00 noon (U.S. Eastern Time) on the business day following publication of this announcement. Neither the content of the website referred to in this announcement nor the content of any other websites accessible from hyperlinks on such website is incorporated into, or forms part of, this announcement.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) — Mural Oncology plc (Nasdaq: MURA) (\u201cMural\u201d)\u00a0announces that, in accordance with the terms of the transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (\u201cXOMA Royalty\u201d), XRA 5 Corp. (\u201cSub\u201d) and Mural announced on August 20, 2025 (the \u201cTransaction Agreement\u201d), the Additional Price Per Share (as defined in the Transaction Agreement) has been finally determined in accordance with Clause 2.4 of the Transaction Agreement as $0.000. As a result, the total cash consideration payable to Mural shareholders on closing of the Acquisition (as defined below) will be $2.035 in cash per share. As previously announced on August 20, 2025, XOMA Royalty, Sub and Mural entered into the Transaction Agreement pursuant to … <\/p>\n

Continue reading “Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-914062","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) — Mural Oncology plc (Nasdaq: MURA) (\u201cMural\u201d)\u00a0announces that, in accordance with the terms of the transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (\u201cXOMA Royalty\u201d), XRA 5 Corp. (\u201cSub\u201d) and Mural announced on August 20, 2025 (the \u201cTransaction Agreement\u201d), the Additional Price Per Share (as defined in the Transaction Agreement) has been finally determined in accordance with Clause 2.4 of the Transaction Agreement as $0.000. As a result, the total cash consideration payable to Mural shareholders on closing of the Acquisition (as defined below) will be $2.035 in cash per share. As previously announced on August 20, 2025, XOMA Royalty, Sub and Mural entered into the Transaction Agreement pursuant to … Continue reading "Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-26T14:04:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty\",\"datePublished\":\"2025-11-26T14:04:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/\"},\"wordCount\":1274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/\",\"name\":\"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=\",\"datePublished\":\"2025-11-26T14:04:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/","og_locale":"en_US","og_type":"article","og_title":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk","og_description":"WALTHAM, Mass. and DUBLIN, Ireland, Nov. 26, 2025 (GLOBE NEWSWIRE) — Mural Oncology plc (Nasdaq: MURA) (\u201cMural\u201d)\u00a0announces that, in accordance with the terms of the transaction agreement between XOMA Royalty Corporation (Nasdaq: XOMA) (\u201cXOMA Royalty\u201d), XRA 5 Corp. (\u201cSub\u201d) and Mural announced on August 20, 2025 (the \u201cTransaction Agreement\u201d), the Additional Price Per Share (as defined in the Transaction Agreement) has been finally determined in accordance with Clause 2.4 of the Transaction Agreement as $0.000. As a result, the total cash consideration payable to Mural shareholders on closing of the Acquisition (as defined below) will be $2.035 in cash per share. As previously announced on August 20, 2025, XOMA Royalty, Sub and Mural entered into the Transaction Agreement pursuant to … Continue reading \"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-26T14:04:34+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty","datePublished":"2025-11-26T14:04:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/"},"wordCount":1274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/","name":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=","datePublished":"2025-11-26T14:04:34+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU5MjgwMyM3Mjk0MTMzIzIyNjIzNDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mural-oncology-announces-final-cash-consideration-payable-on-closing-of-acquisition-by-xoma-royalty\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mural Oncology Announces Final Cash Consideration Payable on Closing of Acquisition by XOMA Royalty"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=914062"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/914062\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=914062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=914062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=914062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}